| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cryptosporidiosis | 26 | 2025 | 27 | 11.890 |
Why?
|
| Cryptosporidium parvum | 25 | 2025 | 25 | 11.620 |
Why?
|
| RNA, Long Noncoding | 15 | 2026 | 21 | 9.380 |
Why?
|
| Epithelial Cells | 28 | 2025 | 104 | 8.110 |
Why?
|
| Intestinal Mucosa | 17 | 2025 | 176 | 7.660 |
Why?
|
| MicroRNAs | 28 | 2026 | 77 | 7.620 |
Why?
|
| Cryptosporidium | 10 | 2025 | 11 | 5.290 |
Why?
|
| Transcription, Genetic | 17 | 2025 | 124 | 4.700 |
Why?
|
| Interferon-gamma | 6 | 2025 | 89 | 3.830 |
Why?
|
| RNA, Protozoan | 7 | 2018 | 7 | 3.530 |
Why?
|
| NF-kappa B | 15 | 2022 | 129 | 3.010 |
Why?
|
| Host-Parasite Interactions | 6 | 2026 | 9 | 2.810 |
Why?
|
| Animals | 38 | 2026 | 3681 | 2.670 |
Why?
|
| Gene Expression Regulation | 18 | 2025 | 290 | 2.550 |
Why?
|
| Mice | 26 | 2025 | 1449 | 2.480 |
Why?
|
| Cell Line | 21 | 2021 | 292 | 2.130 |
Why?
|
| Anti-Infective Agents | 3 | 2023 | 34 | 1.690 |
Why?
|
| Down-Regulation | 9 | 2018 | 109 | 1.660 |
Why?
|
| Inflammation | 7 | 2018 | 287 | 1.560 |
Why?
|
| Interferon Type I | 2 | 2023 | 13 | 1.520 |
Why?
|
| Bile Ducts | 5 | 2012 | 10 | 1.480 |
Why?
|
| RNA, Untranslated | 2 | 2026 | 5 | 1.440 |
Why?
|
| Immunity, Innate | 6 | 2021 | 71 | 1.380 |
Why?
|
| Host-Pathogen Interactions | 3 | 2025 | 17 | 1.340 |
Why?
|
| Signal Transduction | 9 | 2021 | 455 | 1.320 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 3 | 2025 | 3 | 1.240 |
Why?
|
| Humans | 49 | 2026 | 27307 | 1.240 |
Why?
|
| Promoter Regions, Genetic | 8 | 2018 | 103 | 1.230 |
Why?
|
| Receptors, Androgen | 3 | 2013 | 9 | 1.190 |
Why?
|
| p300-CBP Transcription Factors | 3 | 2013 | 6 | 1.190 |
Why?
|
| Epithelium | 3 | 2021 | 31 | 1.110 |
Why?
|
| Mice, Inbred C57BL | 10 | 2025 | 454 | 1.100 |
Why?
|
| RNA, Messenger | 7 | 2021 | 317 | 1.060 |
Why?
|
| Exosomes | 3 | 2019 | 7 | 1.060 |
Why?
|
| Transcriptional Activation | 7 | 2018 | 37 | 1.000 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2021 | 37 | 0.960 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2018 | 193 | 0.940 |
Why?
|
| Up-Regulation | 10 | 2021 | 185 | 0.900 |
Why?
|
| Intestines | 3 | 2021 | 87 | 0.880 |
Why?
|
| Immunity, Mucosal | 3 | 2021 | 17 | 0.850 |
Why?
|
| Protozoan Proteins | 2 | 2025 | 2 | 0.820 |
Why?
|
| Histones | 5 | 2017 | 36 | 0.810 |
Why?
|
| Prostatic Neoplasms | 3 | 2013 | 109 | 0.800 |
Why?
|
| Lipopolysaccharides | 10 | 2021 | 104 | 0.780 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2013 | 16 | 0.780 |
Why?
|
| Microglia | 3 | 2021 | 145 | 0.780 |
Why?
|
| Macrophages | 3 | 2018 | 116 | 0.760 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2021 | 4 | 0.730 |
Why?
|
| Adenosine | 1 | 2021 | 9 | 0.730 |
Why?
|
| beta-Defensins | 2 | 2018 | 3 | 0.680 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 2 | 2010 | 6 | 0.660 |
Why?
|
| Transcription Factor RelA | 2 | 2010 | 20 | 0.650 |
Why?
|
| Transcription Factors | 3 | 2016 | 169 | 0.640 |
Why?
|
| Spleen | 1 | 2019 | 33 | 0.620 |
Why?
|
| RNA Interference | 4 | 2021 | 42 | 0.580 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2018 | 3 | 0.580 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 56 | 0.580 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2018 | 13 | 0.580 |
Why?
|
| Cadherins | 1 | 2018 | 35 | 0.570 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2017 | 10 | 0.570 |
Why?
|
| Apoptosis | 3 | 2016 | 216 | 0.570 |
Why?
|
| Fusion Regulatory Protein 1, Light Chains | 1 | 2017 | 1 | 0.560 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2017 | 2 | 0.560 |
Why?
|
| Interleukin-33 | 1 | 2017 | 3 | 0.560 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2017 | 3 | 0.550 |
Why?
|
| RNA, Small Interfering | 5 | 2021 | 86 | 0.550 |
Why?
|
| Cell Movement | 1 | 2017 | 82 | 0.550 |
Why?
|
| Cell Line, Tumor | 7 | 2018 | 270 | 0.550 |
Why?
|
| Chemokine CX3CL1 | 2 | 2015 | 4 | 0.540 |
Why?
|
| Macrophage Activation | 1 | 2016 | 10 | 0.530 |
Why?
|
| Isothiocyanates | 2 | 2013 | 7 | 0.510 |
Why?
|
| Trans-Activators | 2 | 2015 | 25 | 0.510 |
Why?
|
| RNA-Binding Proteins | 2 | 2015 | 24 | 0.510 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2016 | 2 | 0.500 |
Why?
|
| Macrophages, Peritoneal | 1 | 2016 | 17 | 0.500 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2015 | 2 | 0.500 |
Why?
|
| Gene Silencing | 3 | 2018 | 26 | 0.490 |
Why?
|
| Interleukin-12 | 1 | 2015 | 40 | 0.480 |
Why?
|
| Blotting, Western | 5 | 2020 | 153 | 0.470 |
Why?
|
| Feedback, Physiological | 2 | 2012 | 15 | 0.470 |
Why?
|
| Methylation | 3 | 2021 | 13 | 0.460 |
Why?
|
| Adaptive Immunity | 1 | 2014 | 20 | 0.440 |
Why?
|
| Histone Deacetylases | 1 | 2013 | 12 | 0.420 |
Why?
|
| Antiparasitic Agents | 2 | 2023 | 3 | 0.420 |
Why?
|
| Animals, Newborn | 2 | 2025 | 45 | 0.410 |
Why?
|
| Interleukin-8 | 2 | 2014 | 20 | 0.410 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2012 | 7 | 0.400 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2012 | 20 | 0.400 |
Why?
|
| Collagen Type I | 1 | 2012 | 20 | 0.400 |
Why?
|
| Diarrhea | 3 | 2021 | 37 | 0.390 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2012 | 1 | 0.380 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2012 | 24 | 0.380 |
Why?
|
| Hepatocytes | 1 | 2012 | 12 | 0.380 |
Why?
|
| Phenotype | 1 | 2012 | 313 | 0.370 |
Why?
|
| Biliary Tract | 4 | 2013 | 7 | 0.360 |
Why?
|
| Homeostasis | 1 | 2011 | 70 | 0.350 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 86 | 0.340 |
Why?
|
| Liver | 3 | 2019 | 151 | 0.330 |
Why?
|
| Antigens, CD | 1 | 2010 | 53 | 0.320 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2009 | 14 | 0.320 |
Why?
|
| STAT1 Transcription Factor | 2 | 2024 | 4 | 0.310 |
Why?
|
| Liver Diseases | 1 | 2009 | 35 | 0.300 |
Why?
|
| T-Lymphocytes | 3 | 2018 | 102 | 0.300 |
Why?
|
| DNA Methylation | 1 | 2009 | 165 | 0.290 |
Why?
|
| Luciferases | 3 | 2020 | 28 | 0.290 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2018 | 41 | 0.280 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2020 | 44 | 0.280 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2017 | 7 | 0.280 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2021 | 69 | 0.270 |
Why?
|
| Genes, Reporter | 3 | 2020 | 25 | 0.270 |
Why?
|
| Gastrointestinal Tract | 2 | 2021 | 47 | 0.260 |
Why?
|
| Transcriptome | 2 | 2017 | 91 | 0.260 |
Why?
|
| Cells, Cultured | 5 | 2021 | 527 | 0.260 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2016 | 8 | 0.260 |
Why?
|
| Cyclooxygenase 2 | 2 | 2016 | 31 | 0.250 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2026 | 43 | 0.240 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 46 | 0.240 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2025 | 9 | 0.240 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 606 | 0.240 |
Why?
|
| Cell Proliferation | 3 | 2021 | 184 | 0.230 |
Why?
|
| Male | 9 | 2021 | 14887 | 0.230 |
Why?
|
| Cell Survival | 3 | 2021 | 121 | 0.220 |
Why?
|
| Autophagy | 1 | 2024 | 34 | 0.220 |
Why?
|
| Cytokines | 3 | 2018 | 238 | 0.210 |
Why?
|
| Jurkat Cells | 3 | 2018 | 13 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 125 | 0.210 |
Why?
|
| Dihydrotestosterone | 2 | 2013 | 3 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 146 | 0.200 |
Why?
|
| 3' Untranslated Regions | 2 | 2013 | 7 | 0.190 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2013 | 17 | 0.190 |
Why?
|
| AlkB Homolog 5, RNA Demethylase | 1 | 2021 | 1 | 0.180 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2021 | 6 | 0.180 |
Why?
|
| Binding Sites | 3 | 2010 | 74 | 0.180 |
Why?
|
| GTP-Binding Proteins | 1 | 2021 | 12 | 0.180 |
Why?
|
| GTP Phosphohydrolases | 1 | 2021 | 7 | 0.180 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 12 | 0.180 |
Why?
|
| Circulating MicroRNA | 1 | 2021 | 1 | 0.180 |
Why?
|
| Neurogenesis | 1 | 2021 | 9 | 0.180 |
Why?
|
| Osteosarcoma | 1 | 2021 | 41 | 0.170 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2021 | 47 | 0.170 |
Why?
|
| Response Elements | 2 | 2017 | 16 | 0.170 |
Why?
|
| Toll-Like Receptors | 2 | 2011 | 19 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 61 | 0.170 |
Why?
|
| Cell Line, Transformed | 2 | 2010 | 17 | 0.170 |
Why?
|
| Databases, Genetic | 1 | 2020 | 9 | 0.170 |
Why?
|
| Blotting, Northern | 1 | 2020 | 22 | 0.160 |
Why?
|
| Workflow | 1 | 2020 | 9 | 0.160 |
Why?
|
| In Situ Hybridization | 1 | 2020 | 50 | 0.160 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 218 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 154 | 0.160 |
Why?
|
| Bone Neoplasms | 1 | 2021 | 131 | 0.160 |
Why?
|
| High Mobility Group Proteins | 1 | 2019 | 4 | 0.160 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 208 | 0.160 |
Why?
|
| Child | 1 | 2023 | 1269 | 0.150 |
Why?
|
| Gene Expression Profiling | 2 | 2009 | 143 | 0.150 |
Why?
|
| Age Factors | 1 | 2021 | 779 | 0.150 |
Why?
|
| Immunity | 1 | 2018 | 16 | 0.150 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2018 | 3 | 0.150 |
Why?
|
| Creatinine | 1 | 2018 | 43 | 0.140 |
Why?
|
| Acetylation | 2 | 2015 | 16 | 0.140 |
Why?
|
| Intestinal Diseases | 1 | 2017 | 8 | 0.140 |
Why?
|
| Conserved Sequence | 1 | 2017 | 9 | 0.140 |
Why?
|
| Histocompatibility Antigens | 1 | 2017 | 1 | 0.140 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 2017 | 1 | 0.140 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2017 | 8 | 0.130 |
Why?
|
| HMGB1 Protein | 1 | 2016 | 1 | 0.130 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2016 | 2 | 0.130 |
Why?
|
| Cellular Senescence | 1 | 2016 | 19 | 0.130 |
Why?
|
| U937 Cells | 2 | 2017 | 3 | 0.130 |
Why?
|
| Stem Cells | 1 | 2016 | 39 | 0.130 |
Why?
|
| Coculture Techniques | 2 | 2021 | 33 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2016 | 8 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2013 | 58 | 0.130 |
Why?
|
| Nucleosomes | 1 | 2015 | 3 | 0.120 |
Why?
|
| Flow Cytometry | 2 | 2013 | 112 | 0.120 |
Why?
|
| Gene Expression | 1 | 2016 | 201 | 0.120 |
Why?
|
| Base Sequence | 2 | 2013 | 108 | 0.120 |
Why?
|
| Epigenomics | 1 | 2015 | 21 | 0.120 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 194 | 0.120 |
Why?
|
| Protozoan Vaccines | 1 | 2014 | 1 | 0.110 |
Why?
|
| Antiprotozoal Agents | 1 | 2014 | 9 | 0.110 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2014 | 12 | 0.110 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 1 | 0.110 |
Why?
|
| Cell Adhesion | 2 | 2013 | 33 | 0.110 |
Why?
|
| Ribonuclease III | 1 | 2013 | 3 | 0.100 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2013 | 3 | 0.100 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 5 | 0.100 |
Why?
|
| Receptors, Chemokine | 1 | 2013 | 10 | 0.100 |
Why?
|
| Sporozoites | 1 | 2013 | 1 | 0.100 |
Why?
|
| Cathelicidins | 1 | 2013 | 2 | 0.100 |
Why?
|
| I-kappa B Kinase | 1 | 2013 | 7 | 0.100 |
Why?
|
| Qb-SNARE Proteins | 1 | 2013 | 5 | 0.100 |
Why?
|
| Qc-SNARE Proteins | 1 | 2013 | 5 | 0.100 |
Why?
|
| Antigen Presentation | 1 | 2013 | 16 | 0.100 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2013 | 12 | 0.100 |
Why?
|
| Propidium | 1 | 2012 | 2 | 0.100 |
Why?
|
| Snail Family Transcription Factors | 1 | 2012 | 4 | 0.100 |
Why?
|
| Cardiomyopathies | 1 | 2013 | 28 | 0.100 |
Why?
|
| DNA Primers | 1 | 2012 | 52 | 0.100 |
Why?
|
| Enzyme Activation | 1 | 2013 | 119 | 0.100 |
Why?
|
| In Vitro Techniques | 1 | 2012 | 169 | 0.100 |
Why?
|
| RNA Splicing | 1 | 2012 | 11 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2012 | 258 | 0.100 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2012 | 11 | 0.100 |
Why?
|
| Anthracenes | 1 | 2012 | 5 | 0.100 |
Why?
|
| Flavonoids | 1 | 2012 | 19 | 0.090 |
Why?
|
| RNA | 1 | 2012 | 41 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 29 | 0.090 |
Why?
|
| Pyridines | 1 | 2012 | 34 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 2012 | 80 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 38 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 375 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 117 | 0.090 |
Why?
|
| Immune Tolerance | 1 | 2011 | 16 | 0.090 |
Why?
|
| Integrins | 1 | 2011 | 14 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 30 | 0.090 |
Why?
|
| Th2 Cells | 1 | 2011 | 18 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 22 | 0.090 |
Why?
|
| Antigens, Neoplasm | 1 | 2011 | 42 | 0.090 |
Why?
|
| Imidazoles | 1 | 2012 | 63 | 0.090 |
Why?
|
| Mice, Knockout | 1 | 2012 | 311 | 0.090 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 36 | 0.090 |
Why?
|
| RNA Precursors | 1 | 2010 | 1 | 0.080 |
Why?
|
| Dactinomycin | 1 | 2010 | 7 | 0.080 |
Why?
|
| Protein Biosynthesis | 1 | 2010 | 17 | 0.080 |
Why?
|
| B7-H1 Antigen | 1 | 2010 | 9 | 0.080 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2009 | 2 | 0.080 |
Why?
|
| Genes, Neoplasm | 1 | 2009 | 2 | 0.080 |
Why?
|
| Hydroxamic Acids | 1 | 2009 | 6 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 60 | 0.080 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2009 | 8 | 0.080 |
Why?
|
| DNA, Neoplasm | 1 | 2009 | 25 | 0.080 |
Why?
|
| Azacitidine | 1 | 2009 | 12 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 1 | 2009 | 130 | 0.080 |
Why?
|
| CpG Islands | 1 | 2009 | 55 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 119 | 0.080 |
Why?
|
| Female | 3 | 2021 | 15334 | 0.080 |
Why?
|
| Mutation | 1 | 2010 | 353 | 0.070 |
Why?
|
| Rats | 2 | 2021 | 660 | 0.060 |
Why?
|
| Crystallography, X-Ray | 1 | 2025 | 12 | 0.060 |
Why?
|
| Thioredoxins | 1 | 2025 | 8 | 0.060 |
Why?
|
| Auranofin | 1 | 2025 | 8 | 0.060 |
Why?
|
| Glutathione | 1 | 2025 | 23 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2025 | 65 | 0.060 |
Why?
|
| Models, Molecular | 1 | 2025 | 82 | 0.060 |
Why?
|
| Liquid Biopsy | 1 | 2021 | 6 | 0.040 |
Why?
|
| Intermediate Filament Proteins | 1 | 2021 | 2 | 0.040 |
Why?
|
| Nestin | 1 | 2021 | 4 | 0.040 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2021 | 5 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2021 | 29 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 38 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2021 | 179 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 177 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2021 | 137 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2021 | 631 | 0.040 |
Why?
|
| THP-1 Cells | 1 | 2018 | 3 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 5 | 0.040 |
Why?
|
| Neurons | 1 | 2021 | 340 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2018 | 80 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2017 | 3 | 0.040 |
Why?
|
| RNA Stability | 1 | 2015 | 2 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2015 | 6 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 1807 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 2032 | 0.030 |
Why?
|
| Global Health | 1 | 2014 | 37 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2013 | 1 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2013 | 35 | 0.030 |
Why?
|
| Rats, Transgenic | 1 | 2013 | 19 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2021 | 3551 | 0.020 |
Why?
|
| Antigens | 1 | 2011 | 12 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2011 | 36 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 103 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 87 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2009 | 3 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2009 | 52 | 0.020 |
Why?
|
| Protein Binding | 1 | 2009 | 125 | 0.020 |
Why?
|
| Genome, Human | 1 | 2009 | 45 | 0.020 |
Why?
|
| Adult | 1 | 2021 | 7945 | 0.020 |
Why?
|